| Product Code: ETC9972021 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Onchocerciasis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Onchocerciasis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Onchocerciasis Market - Industry Life Cycle |
3.4 United States (US) Onchocerciasis Market - Porter's Five Forces |
3.5 United States (US) Onchocerciasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United States (US) Onchocerciasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Onchocerciasis Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.8 United States (US) Onchocerciasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Onchocerciasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 United States (US) Onchocerciasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Onchocerciasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about onchocerciasis in the United States |
4.2.2 Government initiatives to control and eliminate onchocerciasis |
4.2.3 Advances in research and development for new treatment options |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatment options |
4.3.2 High cost of treatment and healthcare services |
4.3.3 Lack of healthcare infrastructure in certain regions |
5 United States (US) Onchocerciasis Market Trends |
6 United States (US) Onchocerciasis Market, By Types |
6.1 United States (US) Onchocerciasis Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Onchocerciasis Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United States (US) Onchocerciasis Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.1.4 United States (US) Onchocerciasis Market Revenues & Volume, By Skin Biopsy, 2021- 2031F |
6.1.5 United States (US) Onchocerciasis Market Revenues & Volume, By Mazzotti Test, 2021- 2031F |
6.1.6 United States (US) Onchocerciasis Market Revenues & Volume, By Nodulectomy, 2021- 2031F |
6.1.7 United States (US) Onchocerciasis Market Revenues & Volume, By PCR Test, 2021- 2031F |
6.1.8 United States (US) Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Onchocerciasis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Onchocerciasis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Onchocerciasis Market Revenues & Volume, By Supportive Care, 2021- 2031F |
6.2.4 United States (US) Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Onchocerciasis Market, By Drug |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Onchocerciasis Market Revenues & Volume, By Ivermectin, 2021- 2031F |
6.3.3 United States (US) Onchocerciasis Market Revenues & Volume, By Moxidectin, 2021- 2031F |
6.3.4 United States (US) Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Onchocerciasis Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Onchocerciasis Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Onchocerciasis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Onchocerciasis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Onchocerciasis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 United States (US) Onchocerciasis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 United States (US) Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Onchocerciasis Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Onchocerciasis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United States (US) Onchocerciasis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 United States (US) Onchocerciasis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Onchocerciasis Market Import-Export Trade Statistics |
7.1 United States (US) Onchocerciasis Market Export to Major Countries |
7.2 United States (US) Onchocerciasis Market Imports from Major Countries |
8 United States (US) Onchocerciasis Market Key Performance Indicators |
8.1 Number of diagnosed cases of onchocerciasis |
8.2 Funding allocated towards onchocerciasis research and control programs |
8.3 Percentage of population screened for onchocerciasis |
9 United States (US) Onchocerciasis Market - Opportunity Assessment |
9.1 United States (US) Onchocerciasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United States (US) Onchocerciasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Onchocerciasis Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.4 United States (US) Onchocerciasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Onchocerciasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 United States (US) Onchocerciasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Onchocerciasis Market - Competitive Landscape |
10.1 United States (US) Onchocerciasis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Onchocerciasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here